pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
BDTX-4933
Metastatic Colorectal Cancer
Les Laboratoires Servier SAS
0 catalysts
Preclinical
BEA-17
Glioblastoma Multiforme (GBM)
Beactica Therapeutics AB
0 catalysts
Phase 2
BEAM-201
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$BEAMBeam Therapeutics Inc.
0 catalysts
Preclinical
BG-22
Solid Tumor
← prev
page 12 of 62
next →
131
Pain89
Neurology1
BioStar Pharmaceuticals Inc
0 catalysts
Preclinical
BGA-002
Small-Cell Lung Cancer
Biogenera SpA
0 catalysts
Phase 2
BGB-16673
Refractory Chronic Lymphocytic Leukemia (CLL)
$ONCBeOne Medicines Ltd.
0 catalysts
Phase 1
BGBB-2033
Metastatic Hepatocellular Carcinoma (HCC)
$ONCBeOne Medicines Ltd.
0 catalysts
Phase 1
BGC-515
Malignant Mesothelioma
BridGene Biosciences Inc
0 catalysts
Preclinical
BGI-9004
Malignant Mesothelioma
BridGene Biosciences Inc
0 catalysts
Phase 1
BH-30236
Refractory Acute Myeloid Leukemia
BlossomHill Therapeutics Inc
0 catalysts
Phase 1
BH-3120
Solid Tumor
Hanmi Pharmaceuticals Co Ltd
0 catalysts
Phase 2
BHV-1510
Solid Tumor
$BHVNBiohaven Ltd.
0 catalysts
Phase 1
BHV-1530
Glioblastoma Multiforme (GBM)
$BHVNBiohaven Ltd.
0 catalysts
Phase 2
BI-1206
B-Cell Non-Hodgkin Lymphoma
BioInvent International AB
0 catalysts
Phase 2
BI-1808
Mycosis Fungoides
BioInvent International AB
0 catalysts
Phase 2
BI-836858
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Boehringer Ingelheim International GmbH
0 catalysts
Phase 2
BIO-106
Solid Tumor
BiOneCure Therapeutics Inc
0 catalysts
Phase 1
BJ-001
Solid Tumor
BJ Bioscience Inc
0 catalysts
Phase 1
BJ-005
Solid Tumor
BJ Bioscience Inc
0 catalysts
Phase 1
BLM-11D1
Refractory Acute Myeloid Leukemia
Sichuan Biokin Pharmaceutical Co Ltd
0 catalysts
Phase 1
BLM-14D1
Gastrointestinal Tumor
Sichuan Biokin Pharmaceutical Co Ltd
0 catalysts
Phase 1
BLM-17D1
Endometrial Cancer
Sichuan Biokin Pharmaceutical Co Ltd
0 catalysts
Phase 1
BMS-986416
Diffuse Cutaneous Systemic Sclerosis
Bristol-Myers Squibb Co
0 catalysts
Phase 1
BMS-986497
Myelodysplastic Syndrome (Preleukemia)
Bristol-Myers Squibb Co
0 catalysts
Phase 2
BMX-001
High-Grade Glioma
Biomimetix JV LLC
0 catalysts
Phase 2
BNT-111
Metastatic Melanoma
$BNTXBioNTech SE
0 catalysts
Phase 3
BNT-113
Recurrent Head And Neck Squamous Cell Carcinoma
$BNTXBioNTech SE
0 catalysts
Phase 2
BOLD-100
Colorectal Cancer
Bold Therapeutics Inc
0 catalysts
Phase 2
BOXR-1030
Merkel Cell Carcinoma
SOTIO Biotech AS
0 catalysts
Phase 1
BP-1002
Refractory Acute Myeloid Leukemia
$BPTHBIO-PATH HOLDINGS, INC.
0 catalysts